Page:United States Statutes at Large Volume 120.djvu/2903

 120 STAT. 2872

PUBLIC LAW 109–417—DEC. 19, 2006 enactment of the Pandemic and All-Hazards Preparedness Act. ‘‘(2) REVIEW.—Notwithstanding section 14 of the Federal Advisory Committee Act, a working group of BARDA under this section and the National Biodefense Science Board under section 319M shall each terminate on the date that is 5 years after the date on which each such group or Board, as applicable, was established. Such 5-year period may be extended by the Secretary for one or more additional 5-year periods if the Secretary determines that any such extension is appropriate.’’.

Termination date.

SEC. 402. NATIONAL BIODEFENSE SCIENCE BOARD.

Title III of the Public Health Service Act (42 U.S.C. 241 et seq.), as amended by section 401, is further amended by inserting after section 319L the following: 42 USC 247d–7f.

‘‘SEC. 319M. NATIONAL BIODEFENSE SCIENCE BOARD AND WORKING GROUPS.

‘‘(a) IN GENERAL.— ‘‘(1) ESTABLISHMENT AND FUNCTION.—The Secretary shall establish the National Biodefense Science Board (referred to in this section as the ‘Board’) to provide expert advice and guidance to the Secretary on scientific, technical and other matters of special interest to the Department of Health and Human Services regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. ‘‘(2) MEMBERSHIP.—The membership of the Board shall be comprised of individuals who represent the Nation’s preeminent scientific, public health, and medical experts, as follows— ‘‘(A) such Federal officials as the Secretary may determine are necessary to support the functions of the Board; ‘‘(B) four individuals representing the pharmaceutical, biotechnology, and device industries; ‘‘(C) four individuals representing academia; and ‘‘(D) five other members as determined appropriate by the Secretary, of whom— ‘‘(i) one such member shall be a practicing healthcare professional; and ‘‘(ii) one such member shall be an individual from an organization representing healthcare consumers. ‘‘(3) TERM OF APPOINTMENT.—A member of the Board described in subparagraph (B), (C), or (D) of paragraph (2) shall serve for a term of 3 years, except that the Secretary may adjust the terms of the initial Board appointees in order to provide for a staggered term of appointment for all members. ‘‘(4) CONSECUTIVE APPOINTMENTS; MAXIMUM TERMS.—A member may be appointed to serve not more than 3 terms on the Board and may serve not more than 2 consecutive terms. ‘‘(5) DUTIES.—The Board shall— ‘‘(A) advise the Secretary on current and future trends, challenges, and opportunities presented by advances in biological and life sciences, biotechnology, and genetic engineering with respect to threats posed by naturally occurring infectious diseases and chemical, biological, radiological, and nuclear agents;

VerDate 14-DEC-2004

09:16 Jul 13, 2007

Jkt 059194

PO 00003

Frm 00351

Fmt 6580

Sfmt 6581

E:\PUBLAW\PUBL003.109

APPS06

PsN: PUBL003

�